*3.5.4 Security*

Adverse events are generally mild, nonseriuous and transient and include anterior chamber inflammation, posterior capsular opaciticity, IOP > 10 mmHg above baseline more than 30 days postoperatively, cystoid macular edema, corneal edema and hyphema [11].
